Key points are not available for this paper at this time.
High peripheral blood NLR suggested a poor prognosis for patients with pancreatic cancer, and it could be a novel marker of survival evaluation and could help clinicians develop therapeutic strategies for pancreatic cancer patients.
Jianjun Yang (Thu,) studied this question.